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ABSTRACT Technological advancements in ﬁelds such as molecular genetics and
the human microbiome have resulted in an unprecedented recognition of new bac-
terial genus/species designations by the International Journal of Systematic and Evo-
lutionary Microbiology. Knowledge of designations involving clinically signiﬁcant bac-
terial species would beneﬁt clinical microbiologists in the context of emerging
pathogens, performance of accurate organism identiﬁcation, and antimicrobial sus-
ceptibility testing. In anticipation of subsequent taxonomic changes being compiled
by the Journal of Clinical Microbiology on a biannual basis, this compendium summa-
rizes novel species and taxonomic revisions speciﬁc to bacteria derived from human
clinical specimens from the calendar years 2012 through 2015.
KEYWORDS anaerobes, bacteria, Gram-negative bacteria, Gram-positive bacteria,
taxonomy
Human microbiome studies, particularly those involving genome sequencing, haveresulted in a seeming explosion of novel bacterial taxonomy. While many of these
organisms appear to play a commensal role in site-speciﬁc ecology, some of the
organisms may be of clinical signiﬁcance in various patient populations. Moreover,
enhanced studies of known bacterial genomes in a variety of applications, including
those of an epidemiologic nature, have given rise to revisions and amendments to
accepted bacterial taxonomy. Summaries of microbial taxonomy updates, such as those
introduced in this edition of the Journal of Clinical Microbiology, are essential to routine
practice in the clinical microbiology laboratory.
Since 2014, laboratories subscribing to the College of American Pathologists accred-
itation program have encountered checklist standard MIC.11375 in the context of
biennial inspection exercises. The standard (1) requires laboratories to assimilate “tax-
onomic changes that potentially affect the choice of appropriate antimicrobials to
report and/or the interpretative breakpoints to use.” Cited as an example for the
context of this standard is the Gram-negative bacillus with the former taxonomic
designation Actinobacillus actinomycetemcomitans. The taxonomic revision in 1985 (2)
resulting in organism classiﬁcation within the genus Haemophilus subsequently en-
abled antimicrobial susceptibility testing of clinically signiﬁcant isolates using standards
outlined in Table 2E of CLSI supplement M100S (example provided in [3]). Haemophilus
test medium, with a 16- to 18-hour incubation in 5% CO2 enrichment, could be utilized
for disk diffusion. Haemophilus test medium broth could also be inoculated for broth
microdilution testing with 20- to 24-hour incubation in ambient air.
Subsequent reclassiﬁcation of this organism into the genus Aggregatibacter (4) has
resulted in the transition of susceptibility testing guidelines to those speciﬁc to (former)
HACEK group organisms (Aggregatibacter spp., Cardiobacterium spp., Eikenella cor-
rodens, and Kingella spp.) in Table 9 of the CLSI guideline M45 (5).
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The shift of the former A. actinomycetemcomitans from Table 2E of the CLSI M100S
supplement (3) to the M45 guideline (5) also impacted tested and reported anti-
infective agents. While MIC interpretive criteria remained largely unchanged for
trimethoprim-sulfamethoxazole, rifampin, tetracycline, ampicillin, macrolide agents,
and -lactam/-lactamase inhibitor combinations between the two documents, the
number of reportable ﬂuoroquinolone agents via broth microdilution and disk diffusion
testing in a past M100S supplement (3) was reduced from nine to two in the current
M45 guideline (5). These two agents, levoﬂoxacin and ciproﬂoxacin, are only assessed
by broth microdilution and now possess intermediate and resistant interpretive criteria.
Similarly, the number of reportable cephem agents (ﬁfteen) in a previous M100S
supplement was reduced to two for Aggregatibacter spp. in the context of the M45
guideline; intermediate and resistant interpretive criteria now exist. Penicillin suscep-
tibility testing is newly available per the CLSI M45 guideline, along with Aggregatibacter
genus-speciﬁc MIC interpretive criteria for carbapenem susceptibility testing. In an
analogous fashion, clinically signiﬁcant organisms in generic CLSI classiﬁcations, such as
“other non-Enterobacteriaceae” or “Streptococcus spp. viridans group,” could hypothet-
ically be moved into categories that have alternative susceptibility testing guidelines or
that do not allow for any testing.
The accurate identiﬁcation of organisms is important for understanding the epide-
miology of emerging pathogens. One contemporary example of this paradigm resides
within the newly described taxon Elizabethkingia anophelis. This oxidase-positive Gram-
negative bacillus was ﬁrst isolated from the midgut of an Anopheles gambiae mosquito
originating from McCarthy Island, The Gambia (6). Full-gene 16S rRNA sequence
similarities of 98.6% and 98.2% were reported to strains Elizabethkingia meningoseptica
ATCC 13253T and Elizabethkingia miricola GTC 862T, respectively. An initial attribution
of clinical signiﬁcance (7) involved a case of neonatal meningitis in Bangui, Central
African Republic. Although it was identiﬁed as E. meningoseptica by biochemical
analysis, full 16S rRNA gene sequencing of this isolate resulted in a deﬁnitive identiﬁ-
cation as E. anophelis. On the basis of geographic location and discovery origin, it was
originally hypothesized that mosquito vectors were central to E. anophelis disease
epidemiology.
However, Balm et al. (8) chronicled an E. meningoseptica outbreak in cardiothoracic
and surgical intensive care units of a tertiary Singapore hospital. The organism was
isolated from blood and respiratory specimens and identiﬁed by matrix-assisted laser
desorption ionization–time of ﬂight mass spectrometry (MALDI-TOF MS). Initial epide-
miologic relatedness between the clinical isolates and E. meningoseptica isolates de-
rived from sampling of water taps/aerators was established by repetitive element
palindromic PCR. Subsequent 16S rRNA sequencing and whole-genome alignment
identiﬁed the outbreak strains as being E. anophelis. Additional genetic determinants
were consistent with the clinical course (antimicrobial treatment failure and mortality)
in a number of patients.
Moreover, Lau et al. (9) reported three cases of E. anophelis sepsis from one Hong
Kong inpatient facility. Neonatal meningitis was additionally diagnosed in two cases,
and the third involved a maternal chorioamnionitis related to one neonatal case. The
isolates were originally identiﬁed as E. meningoseptica by both a commercial biochem-
ical system and MALDI-TOF MS (scores 1.8). Full-gene 16S rRNA sequencing revealed
99.1% to 99.9% identity to E. anophelis R26T and 97.4% to 99.9% identity to GenBank
E. meningoseptica deposits. Draft genome sequencing not only identiﬁed the isolates as
E. anophelis, but also implicated perinatal vertical transmission in two cases.
Lau and colleagues (10) expanded clinical and epidemiologic analyses of Elizabeth-
kingia spp. bacteremia to ﬁve regional Hong Kong hospitals in the context of additional
non-glucose-fermenting Gram-negative bacilli (including Chryseobacterium and Flavo-
bacterium spp.). Bacteremia caused by Elizabethkingia spp. was associated with clinically
signiﬁcant infection (P 0.00009), positive cultures from additional sources (P 0.005),
higher complication rates (P  0.01), and increased attributable mortality rates (P 
0.025) compared to those of bacteremia caused by non-Elizabethkingia spp. Moreover,
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81% of Elizabethkingia spp. bacteremic episodes were related to E. anophelis, as
conﬁrmed by full-gene 16S rRNA sequencing. The mortality rate in these patients was
23.5% (4/17), while none of the three E. meningoseptica bacteremia cases was fatal.
Patients with E. anophelis bacteremia carried additional clinical diagnoses of
community-acquired or nosocomial pneumonia (29.4% of cases), catheter-related bac-
teremia (23.5%), and neonatal meningitis (17.6%).
Analogous to the original Hong Kong report (9), all E. anophelis isolates were
originally identiﬁed as E. meningoseptica by a commercial biochemical system; nearly
60% were identiﬁed as E. meningoseptica by MALDI-TOF MS. Database revision by the
addition of seven E. anophelis spectra facilitated the identiﬁcation of all E. anophelis
isolates. An increased resistance to piperacillin and co-trimoxazole was observed within
the E. anophelis collection compared to that of the limited subset of E. meningoseptica
isolates (10). In summary, the recognition of current bacterial taxonomy can assist in
future epidemiologic and prognostic delineations of Elizabethkingia spp. infections and
additional emerging infectious agents.
Attempts to summarize and centralize taxonomic changes into a single resource
were previously undertaken (11, 12), and there have been recent attempts to renew this
practice (13, 14). The following compendium of clinically signiﬁcant bacterial taxonomy
changes from the calendar years 2012 to 2015 attempts to provide a comprehensive
capstone for the biannual updating of bacterial taxonomy by editors of the Journal of
Clinical Microbiology.
METHODS AND DATA
Validly published novel (Table 1) and revised (Table 2) taxa pertinent to pro-
karyotic species must meet one of two requirements: (i) an original investigation
published in the International Journal of Systematic and Evolutionary Microbiology
(IJSEM) or (ii) a study published in an alternative journal, with later inclusion on an
approved list in IJSEM. Journals that publish studies reporting new taxa that may be
relevant to the practice of clinical microbiology include Antonie Van Leeuwenhoek,
Current Microbiology, International Journal of Medical Microbiology, Standards in
Genomic Sciences, and Systematic and Applied Microbiology. Six times per year, IJSEM
publishes papers entitled “List of new names and new combinations previously
effectively, but not validly, published” (example provided in [69]). To be considered
for inclusion on this approved list, authors must submit a copy of the published
manuscript to the editorial ofﬁce of IJSEM for conﬁrmation that all the elements
necessary for valid publication have been met. In addition, type strains are to be
deposited into two recognized culture collections in separate nations. Taxa on
these approved lists may be subject to reclassiﬁcation on the basis of a synonym
designation or transfer to another genus. Accepted taxa within Tables 1 and 2 that
were previously published outside IJSEM are represented by appropriate footnoting.
In such fashion, all issues of IJSEM that were published between January 2012
and December 2015 were searched for original articles describing new species
taxonomy or for accepted changes in taxonomic nomenclature. This audit was
further ﬁltered by organisms recovered from human sources. When an initial
organism reservoir could not be ascertained, PubMed primary literature searches
(U.S. National Library of Medicine and the National Institutes of Health) of the novel
or revised taxon were utilized to attempt to index subsequent case reports for
further investigation; several of these case reports are referenced throughout this
report. A number of IJSEM publications (examples provided in [35, 70–75]) simply
identiﬁed isolates as being derived from a speciﬁc specimen source (including
sterile body sites), but did not provide contextual clinical data. Therefore, in these
scenarios (including a number of novel taxa derived from blood culture), clinical
signiﬁcance of these taxa was interpreted as “not established.” Future studies may
be necessary to characterize the true clinical signiﬁcance of novel taxa (76).
Twice per year, IJSEM publishes papers entitled “Notiﬁcation of changes in
taxonomic opinion previously published outside the IJSEM.” The journal publicizes
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these changes in taxonomic opinion simply as a service to bacteriology, rather than
statements of validly published or approved taxonomy. Two such examples of
taxonomic opinion (77, 78) are presented in Table 2, with antecedent primary
referenced literature (79, 80). These entries have been included with the goal of
revisiting them in future Journal of Clinical Microbiology compendia to either
ascertain true clinical signiﬁcance or to determine if ofﬁcial taxonomic status has
been granted.
RESULTS AND DISCUSSION
Table 1 lists the new taxa recovered from humans stratiﬁed by Gram reaction and
morphology. Many of the new genera and species were likely discovered from studies
of the human microbiome. Much of what is listed, while recovered from human clinical
material, has unknown clinical signiﬁcance. There are a few exceptions that warrant
emphasis.
GRAM-POSITIVE COCCI
Seven new Streptococcus species were characterized during the study period, as
highlighted in Table 1. Streptococcus tigurinus, a new member of the Streptococcus mitis
group, was discovered by Zbinden et al. in 2012, when it was recovered from the blood
and aortic valve of a 74-year-old Swiss patient with endocarditis (15, 16). The authors
performed a retrospective review of their institution’s 16S rRNA gene sequence data-
base in the 10-year period prior to 2012, and a total of 15 patients with S. tigurinus
infections were discovered (16). A review of the charts revealed that all of the infections
were serious and invasive and included 12 cases of bacteremia, seven of which were
from patients with endocarditis (16). Other invasive infections included spondylodisci-
tis, prosthetic joint infections, meningitis, encephalitis, and empyema (16). Others have
subsequently reported similar severe infections in patients from Korea (17), Japan (18),
and the United States (19). The high virulence potential of this organism has been
demonstrated in a rat model of endocarditis wherein it was demonstrated that S.
tigurinus strains have increased abilities to resist macrophage-mediated phagocytosis
and to invade endothelial cells (20). The oral cavity is the presumed source of the
organism. An initial study found that this organism was not prevalent in the saliva of
healthy volunteers (16). However, using more sensitive molecular techniques, the same
group obtained saliva and pooled plaque samples from a non-periodontitis control
group and a group with periodontitis (21). The overall prevalence of S. tigurinus was
53% in 51 patients and there was no difference in the frequencies of detection between
the two groups (21). MALDI-TOF MS misidentiﬁes S. tigurinus as Streptococcus oralis,
Streptococcus pneumoniae, or other member of themitis group with scores2.0 (16, 19,
22). Identiﬁcation requires the use of 16S rRNA partial or full-gene sequencing or other
molecular methods (21).
Two new subspecies of the coagulase-negative Staphylococcus petrasii have been
characterized. Subspecies jettensis was recovered from wounds and implicated in
bacteremia, whereas subspecies pragensis is believed to have caused prostatitis (23–
25). One new species of coagulase-positive Staphylococcus, Staphylococcus argenteus,
was isolated from the blood of a person in Australia. This organism is phenotypically
very similar to S. aureus and has likely been misidentiﬁed as such (26). The 16S rRNA
gene sequence (1,474 nucleotide [nt]) of S. argenteus is identical to that of S. aureus.
However, whole-genome sequencing indicates that they are separate species. In addi-
tion, the proteomics proﬁle of S. argenteus using MALDI-TOF MS is different from that
of S. aureus (26). A study in Thailand demonstrated that 4.1% of isolates believed to be
S. aureus were subsequently determined to be S. argenteus (27). This organism was
associated primarily with community-acquired skin and soft tissue infections, although
bacteremia and bone and joint infections were seen in three and two patients,
respectively (27).
Similar to other Gemella species, the two new additions to the genus, G. taiwanensis
and G. parahaemolysans, were isolated from blood cultures and are believed to be a
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cause of opportunistic infections in immunocompromised patients (28). All of the
patients from whom these isolates were recovered had signiﬁcant comorbidities,
including various types of solid tumors (28). These organisms grow slowly on 5% sheep
blood agar and are nonhemolytic. They are easily decolorized during Gram staining
(28). Biochemical tests can be used to differentiate them from other species of Gemella
(28).
GRAM-POSITIVE RODS
Many aerobic or facultatively anaerobic Gram-positive rods were discovered during
the 4-year period of this review. The new species of lactobacilli were recovered from the
feces of patients who were otherwise healthy and likely represent a component of the
normal intestinal microbiota (29, 30). Several new aerobic actinomycetes in the Nocar-
dia and Gordonia genera were recovered from patients with pneumonia, thereby
contributing to the growing list of opportunistic pathogens in immunocompromised
patients. Two new genera were also described. Hazenella coriacea grows optimally
between 42 and 45°C and was recovered from the blood of three separate patients,
although the details of their illnesses were not provided (31). Canibacter oris was
recovered from both a swab and purulent material from an infected dog-bite wound on
the ﬁnger of a 58-year-old patient in Australia (32).
GRAM-NEGATIVE COCCI
Two new Gram-negative cocci have been characterized. Neisseria oralis (33) is a new
species that is found in the human oral cavity and is associated with a variety of
infections. The clinical signiﬁcance of the new genus and species Faucicola mancuni-
ensis, recovered from the tonsils of an otherwise healthy woman, has not been
established (34).
FACULTATIVE GRAM-NEGATIVE RODS
With respect to novel Gram-negative bacillus taxa, the oxidase-positive Psychrobac-
ter sanguinis sp. nov. was ﬁrst identiﬁed from four archival blood culture isolates
originating from New York (35). Clinical signiﬁcance was uncertain among any of these
cases, as pertinent clinical data were not provided. Full-gene 16S rRNA sequencing
reported 99.7% genetic similarity to Psychrobacter sp. PRwf-1, a strain originating from
a ﬁsh species caught in Puerto Rico. The aquatic strain was subsequently reclassiﬁed as
P. sanguinis. A French group recently reported a case of post-neurosurgical meningitis
with P. sanguinis etiology (36). An external ventricular drain was instilled into a
64-year-old female to relieve elevated intracranial pressure. Approximately 1 week after
the procedure, the organism was cultivated following a lumbar puncture. It was
hypothesized that the patient repeatedly touched the drain with her bare hands,
facilitating the introduction of organisms from an environmental (nosocomial) source.
In 1985, Harvey and Greenwood (37) reported the isolation of Campylobacter fetus
from a pet turtle in the context of three clinically ill household members and concom-
itant isolation of Salmonella enterica serovar Agona. Molecular analysis of a C. fetus
subsp. fetus blood culture isolate derived from a precursor T lymphocyte acute lym-
phoblastic leukemia patient indicated a reptilian origin (38). This isolate and other
archival human strains were paired with ﬁve C. fetus-like organisms from reptiles,
subjected to a number of characterizations (including MALDI-TOF MS and whole-
genome sequencing), and granted the novel taxon Campylobacter fetus subsp. testu-
dinum subsp. nov. (39). Epidemiologic investigation indicated that afﬂicted individuals
were largely Asian men who reported consumption of Asian foods or had previous
exposure to reptiles (40).
ANAEROBES
Many new anaerobes have been discovered. Some have been recovered from the
stool of healthy children and adults and likely represent components of the normal
microbiota. Others have been isolated from dental plaque, but whether they cause
periodontal disease is unclear at present. A few organisms are worth highlighting.
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Among the Gram-positive anaerobes, two new Peptoniphilus species, namely, duerdenii
and koenoeneniae were recovered from abscesses of the vagina and buttocks, respec-
tively (41). Actinobaculum schaalii has been moved into the genus Actinotignum. The
three species in this genus, schaalii, urinale, and sanguinis, are part of the urinary
microbiota, but they are also associated with urinary tract infections in men and young
children (42). MALDI-TOF MS can identify these species, and the correct identiﬁcation
is important, as A. schaalii, the most common pathogen in the genus, is resistant to
trimethoprim-sulfamethoxazole and ciproﬂoxacin, which are the agents commonly
used for the treatment of urinary tract infections (42). Atopobium deltae, another novel
Gram-positive anaerobe, was recovered from the blood of a patient with Fournier’s
gangrene (43). Most of the newly discovered Gram-negative anaerobes have not been
clearly associated with clinical infections, except for the new genus and species
Eisenbergiella tayi (44), which was associated with bacteremia in an elderly patient. Of
the spirochetes recently characterized, Leptospira mayottensis has been associated with
clinical disease in patients from Mayotte in the Indian Ocean (45).
TAXONOMIC REVISIONS
Table 2 lists the taxonomic revisions for organisms recovered from humans, strati-
ﬁed by Gram reaction and morphology. A recent report describing the successful
culture propagation of what was formerly classiﬁed as “Candidatus Helicobacter hei-
lmannii” from feline gastric mucosa resulted in its assignment to the taxon Helicobacter
heilmannii sp. nov. (46). While most descriptions of this organism are associated with
veterinary bacteriology, evidence does exist for the presence of this organism in human
tissue (reviewed in reference 47).
Aeromonas hydrophila subsp. dhakensis and Aeromonas aquariorum were reclassiﬁed
in 2013 under the singular taxon Aeromonas dhakensis sp. nov. comb. nov. (48). Formal
acceptance by the IJSEM was granted in 2015 (49). The initial characterization of A.
hydrophila subsp. dhakensis occurred in the context of diarrheal illness in Bangladesh
(50). In addition to gastroenteritis, reports have suggested a signiﬁcant distribution of
(the former) A. aquariorum extraintestinal infections in a variety of geographic locations
(51, 52). Chen et al. (53) reviewed 80 cases of Aeromonas spp. wound infections in
Taiwan. It was found that 46.3% of these infections were caused by A. dhakensis, while
16.3% were of A. hydrophila etiology. Compared to other Aeromonas spp., A. dhakensis
was also associated with antecedent environmental water exposure, bioﬁlm formation,
and increased in vitro cytotoxicity. Furthermore, the organism generated increased MIC
values for ceftriaxone, gentamicin, and imipenem.
Wautersiella falsenii was reclassiﬁed in 2014 as Empedobacter falsenii comb. nov. (54).
Twenty-six human isolates from Belgium (including blood, ear discharge, oral cavity,
pleural ﬂuid, pus, respiratory tract, wound, and vaginal swab) contributed to the initial
W. falsenii designation (55). Again, clinical manifestations of illness were not described
in this report. van der Velden et al. (56) presented the case of a febrile 1-year-old girl
with pyelonephritis caused by W. falsenii. The identiﬁcation of the organism was
facilitated by MALDI-TOF MS and conﬁrmed by partial-gene 16S rRNA sequencing. An
intravenous 2-week ciproﬂoxacin regimen brought about clinical and microbiologic
improvement. Traglia et al. (57) described the isolation of E. falsenii from a cervical neck
abscess specimen obtained from an 18-year-old female with acute otitis media. Similar
to the previous clinical report (56), the E. falsenii isolate exhibited decreased suscepti-
bilities to colistin, ceftazidime, piperacillin-tazobactam, representative carbapenems,
and additional -lactam/-lactamase inhibitor combinations.
POTENTIAL EMERGING PATHOGENS
While not included within the formal tables of this review, the following encom-
pass examples of new taxa that could conceivably transcend into the realm of
human clinical disease. Rickettsia buchneri sp. nov. (58) is a Gram-negative bacillus
isolated from ovaries of the Ixodes scapularis vector already known to deliver a
number of bacterial and parasitic species to accidental human hosts. Mediannikov
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et al. (59) isolated and characterized the Gram-negative bacillus Bartonella senega-
lensis sp. nov. from the soft tick Ornithodoros sonrai, a vector of relapsing fever. This
novel taxon was subsequently approved by IJSEM (60). Klebsiella michiganensis sp.
nov. (61) is a newly characterized Gram-negative bacillus isolated from a toothbrush
holder, with taxonomy subsequently accepted by IJSEM (62). Brady et al. (63)
described taxonomic reclassiﬁcation of Enterobacter oryzae and Enterobacter turi-
censis as Kosakonia oryzae comb. nov. and Cronobacter zurichensis nom. nov.,
respectively, with subsequent acceptance by IJSEM (64). In antecedent publications,
the former E. oryzae and E. turicensis were recovered from wild rice (65) and fruit
TABLE 2 Revised bacterial taxa between January 2012 and December 2015
Old name Revised name Other information References
Aerobic Gram-positive rod
Bacillus massiliensis Lysinibacillus massiliensis comb. nov. Isolated from human cerebrospinal ﬂuid 153, 154
Anaerobic Gram-positive cocci
Ruminococcus obeum Blautium obeum comb. nov. Isolated from human feces 155
Anaerobic Gram-negative rods
Prevotella tannerae Alloprevotella tannerae gen. nov. Endodontic infections 138
Biﬁdobacterium stercoris Biﬁdobacterium adolescentis Isolated from human feces 156
Anaerobic Gram-positive rods
Eubacterium saburreum Lachnoanaerobaculum saburreum comb. nov. Isolated from dental plaque 125
Clostridium hathewayi Hungatella hathewayi gen. nov., comb. nov. Isolated from human feces 157
Actinobaculum urinale Actinotignum urinale comb. nov. Urinary tract infections 132
Actinobactulum schaalii Actinotignum schaalii gen. nov., comb. nov. Urinary tract infections 132
Gram-negative cocci
Neisseria mucosa var. heidelbergensis Neisseria oralis Neisseria oralis sp. nov. referenced in Table 1 of
this minireview
33, 158
Aerobic and facultative Gram-negative rods
“Candidatus Helicobacter heilmannii” Helicobacter heilmannii sp. nov. Newly recognized due to in vitro cultivation of the
organism, signiﬁcance in humans described in
reference 47
46, 47
Cronobacter genomospecies 1 Cronobacter universalis sp. nov. Pathogenicity of strain 731 previously
demonstrated in leg infection
159
Pasteurella species B Pasteurella oralis sp. nov. Type strain isolated in 1981 from cat bite wound
of human
160
Selected CDC group II-i isolates Sphingobacterium mizutaii Two isolates recovered from blood culture (one
from patient with septicemia)
161
Yersinia frederiksenii genospecies 2 Yersinia massiliensis Phylogenetic analysis grouped 15 strains of Y.
frederiksenii genospecies 2/Y. massiliensis apart
from Y. frederiksenii genospecies 1 and 3
162
142 group Chryseobacterium bernardetii sp. nov. Isolated from tongue swab, sputum, blood, ﬁnger
abscess
163
78 group Chryseobacterium nakagawai sp. nov. Isolated from kidney abscess, urine 163
212 group (contribution of CDC groups IIc
and IIe)
Chryseobacterium taklimakanense comb. nov. Isolated from blood, wound, cerebrospinal ﬂuid 163
Aeromonas hydrophila subsp. dhakensis Aeromonas dhakensis sp. nov. comb nov. Pathogenicity in humans described in references
50, 53
48a, 50, 53
Aeromonas aquariorum Aeromonas dhakensis sp. nov. comb nov. Pathogenicity in humans described in references
51, 52
48a, 51, 52
Aeromonas hydrophila subsp. anaerogenes Aeromonas caviae Original taxonomy discussed in reference 164 79b, 164
Enterobacter gergoviae Pluralibacter gergoviae comb. nov. E. gergoviae sp. nov. pathogenicity ﬁrst
characterized in reference 165
63c, 165
Enterobacter amnigenus Lelliottia amnigena comb. nov. One recent example of E. amnigenus pathogenicity
was bloodstream isolate harboring both blaKPC
and rmtB on single plasmid, as published in
reference 166
63c, 166
Achromobacter genogroup 2 Achromobacter insuavis Isolated from cystic ﬁbrosis, non-cystic ﬁbrosis
patient sputum
167d
Achromobacter genogroup 5 Achromobacter aegrifaciens Isolated from cystic ﬁbrosis, non-cystic ﬁbrosis
patient sputum
167d
Achromobacter genogroup 7 Achromobacter anxifer Isolated from cystic ﬁbrosis patient sputum 167d
Achromobacter genogroup 14 Achromobacter dolens Isolated from cystic ﬁbrosis, non-cystic ﬁbrosis
patient sputum
167d
Wautersiella falsenii Empedobacter falsenii comb. nov. Pathogenicity in humans described in references
56, 57
54–57
Rahnella genomospecies 2 Rahnella variigena sp. nov. Type strain isolated from human burn specimen 80e
aTaxonomic designation subsequently accepted in validation list no. 161 (49).
bTaxonomic designation not recognized on validation list in International Journal of Systematic and Evolutionary Microbiology; offered as component of changes in
taxonomic opinion no. 19 (77).
cTaxonomic designation subsequently accepted in validation list no. 154 (64).
dTaxonomic designation subsequently accepted in validation list no. 155 (149).
eTaxonomic designation not recognized on validation list in International Journal of Systematic and Evolutionary Microbiology; offered as component of changes in
taxonomic opinion no. 22 (78).
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powder (66), respectively. Stephan et al. (67) published the taxonomic reclassiﬁca-
tion of Enterobacter pulveris as Franconibacter pulveris comb. nov. Isolation of this
organism from infant formula was previously described (68). These organisms with
inferred pathogenic potential provide the basis for follow-up database searches in
future Journal of Clinical Microbiology taxonomy compendia.
In summary, over the 4-year period of this review, both the expansion of new
technologies and the characterization of the human microbiome have led to the
discovery of a broad range of bacterial organisms that are part of the normal human
microbiota. In addition, the new tools have enabled a more comprehensive assess-
ment of closely related pathogens and the discovery of novel clinically signiﬁcant
organisms. We attempted to highlight those pathogens and, where possible, to
describe their epidemiologic and clinical niches.
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